- Zacks•18 hours ago
Ironwood Pharmaceuticals, Inc. (IRWD) reported an adjusted loss of 12 cents per share in the fourth quarter of 2016, narrower than the Zacks Consensus Estimate of a loss of 23 cents but slightly wider than the year-ago loss of 11 cents.
- Associated Press•2 days ago
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 9 cents. Losses, adjusted for amortization gains and non-recurring gains, were 12 cents per share. The results exceeded ...
- Business Wire•2 days ago
Ironwood Pharmaceuticals, Inc. , a commercial biotechnology company, today provided an update on its fourth quarter and full year 2016 results and recent business activities.
IRWD : Summary for Ironwood Pharmaceuticals, Inc. - Yahoo Finance
Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||11.13 x 100|
|Day's Range||16.39 - 17.49|
|52 Week Range||8.85 - 17.49|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-29.54|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|